Pulmonary Cyclooxygenase-1 (COX-1) and COX-2 Cellular Expression and Distribution After Respiratory Syncytial Virus and Parainfluenza Virus Infection
- 1 February 2010
- journal article
- research article
- Published by Mary Ann Liebert Inc in Viral Immunology
- Vol. 23 (1), 43-48
- https://doi.org/10.1089/vim.2009.0042
Abstract
Prostaglandins (PGs) play an important role in pulmonary physiology and various pathophysiological processes following infection. The initial step in the biosynthesis of PGs is regulated by two distinct cyclooxygenase enzymes, cyclooxygenase-1 (COX-1) and COX-2. The goal of this study was to investigate the pulmonary cellular localization and distribution of COX-1 and COX-2 in a neonatal lamb model following respiratory syncytial virus (RSV) and parainfluenza virus 3 (PI3) infection, organisms that also cause significant respiratory disease in children. No significant differences were seen in pulmonary COX-1 expression at various microanatomical locations following RSV or PI3 infection compared to controls. In contrast, COX-2 was upregulated following RSV and PI3 infection. Strong expression was restricted to bronchial and bronchiolar epithelial cells and macrophages, while minimal expression was present in the same microanatomical locations in the uninfected lungs. Other microanatomical locations in both the controls and the infected lungs lacked expression. This work suggests that during RSV or PI3 infection: (1) COX-1 cellular expression is not altered, (2) COX-2 cellular expression is upregulated in airway bronchiolar and bronchial epithelial cells and macrophages, (3) respiratory epithelium along with macrophages are important microanatomical compartments regulating the host inflammatory response during viral infection, and (4) COX-2 may be a potential target for RSV and PI3 therapy.Keywords
This publication has 48 references indexed in Scilit:
- Pathophysiology of Cyclooxygenase Inhibition in Animal ModelsToxicologic Pathology, 2009
- Pulmonary and Cardiorenal Cyclooxygenase-1 (COX-1), -2 (COX-2), and Microsomal Prostaglandin E Synthase-1 (mPGES-1) and -2 (mPGES-2) Expression in a Hypertension ModelMediators of Inflammation, 2007
- Immunopathogenesis of Respiratory Syncytial Virus BronchiolitisThe Journal of Infectious Diseases, 2007
- Prostanoids as pharmacological targets in COPD and asthmaEuropean Journal of Pharmacology, 2006
- Airway eicosanoids in acute severe respiratory syncytial virus bronchiolitisThe Journal of Pediatrics, 2004
- Enhanced Surfactant Protein and Defensin mRNA Levels and Reduced Viral Replication during Parainfluenza Virus Type 3 Pneumonia in Neonatal LambsClinical and Vaccine Immunology, 2004
- Rhinovirus Infection Increases 5‐Lipoxygenase and Cyclooxygenase‐2 in Bronchial Biopsy Specimens from Nonatopic SubjectsThe Journal of Infectious Diseases, 2002
- Regulation of the inducible cyclo‐oxygenase pathway in human cultured airway epithelial (A549) cells by nitric oxideBritish Journal of Pharmacology, 1997
- Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes.JCI Insight, 1994
- Effects of Transforming Growth Factor β and Interleukin-1β on Expression of Cyclooxygenase 1 and 2 and Phospholipase A2 mRNA in Lung Fibroblasts and Endothelial Cells in CultureBiochemical and Biophysical Research Communications, 1993